| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
801 |
781 |
$81K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
511 |
487 |
$74K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
183 |
163 |
$49K |
| 80053 |
Comprehensive metabolic panel |
1,098 |
1,019 |
$14K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
355 |
347 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
353 |
345 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,362 |
1,258 |
$10K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
132 |
126 |
$6K |
| 87081 |
|
822 |
783 |
$5K |
| J3490 |
Unclassified drugs |
1,913 |
1,338 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
135 |
121 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
106 |
92 |
$2K |
| 80306 |
|
49 |
48 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
758 |
688 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
54 |
52 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
148 |
54 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
94 |
85 |
$1K |
| 81001 |
|
345 |
325 |
$959.85 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$665.70 |
| 86703 |
|
39 |
37 |
$434.12 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
12 |
$415.76 |
| 86780 |
|
26 |
25 |
$331.97 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$238.72 |
| 84484 |
|
31 |
29 |
$237.08 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26 |
24 |
$201.40 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20 |
12 |
$182.49 |
| J2704 |
Injection, propofol, 10 mg |
36 |
25 |
$134.16 |
| 85027 |
|
16 |
13 |
$74.10 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |